Revelation Biosciences (REVB) Short Interest Ratio & Short Volume $1.59 -0.03 (-1.85%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Revelation Biosciences Short Interest DataCurrent Short Interest47,100 sharesPrevious Short Interest84,500 sharesChange Vs. Previous Month-44.26%Dollar Volume Sold Short$88,077.00Short Interest Ratio0.1 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares1,630,000 sharesFloat Size1,630,000 sharesShort Percent of Float2.89%Today's Trading Volume19,255 sharesAverage Trading Volume459,592 sharesToday's Volume Vs. Average4% Short Selling Revelation Biosciences ? Sign up to receive the latest short interest report for Revelation Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartREVB Short Interest Over TimeREVB Days to Cover Over TimeREVB Percentage of Float Shorted Over Time Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Revelation Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/202447,100 shares $88,077.00 -44.3%2.9%0.1 $1.87 6/30/202484,500 shares $161,395.00 +128.4%5.2%0.1 $1.91 6/15/202437,000 shares $81,770.00 +68.2%2.3%0.1 $2.21 5/31/202422,000 shares $41,140.00 -11.3%1.4%0.3 $1.87 5/15/202424,800 shares $48,360.00 +40.1%1.5%0.2 $1.95 4/30/202417,700 shares $37,299.21 -4.3%1.1%0.1 $2.11 Get the Latest News and Ratings for REVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Revelation Biosciences and its competitors with MarketBeat's FREE daily newsletter. 4/15/202418,500 shares $33,762.50 -43.6%1.1%0 $1.83 3/31/202432,800 shares $89,872.00 No Change8.3%0.1 $2.74 3/15/202432,800 shares $79,048.00 -31.5%8.3%0.1 $2.41 2/29/202447,900 shares $174,835.00 +32.7%12.3%0.1 $3.65 2/15/202436,100 shares $109,022.00 -70.0%9.2%0.1 $3.02 1/31/2024120,200 shares $1.06 million +526.0%30.8%0.6 $8.80 1/15/2024577,000 shares $8.20 million +27.7%9.3%5.8 $14.22 12/31/2023451,700 shares $226,166.19 +4.7%7.3%6.7 $0.50 12/15/2023431,400 shares $237,701.40 +1,878.9%7.0%7.2 $0.55 11/30/202321,800 shares $15,763.58 -29.5%0.4%0.4 $0.72 11/15/202330,900 shares $19,476.27 +134.1%0.5%0.6 $0.63 10/31/202313,200 shares $7,933.20 -50.6%0.2%0.2 $0.60 10/15/202326,700 shares $18,206.73 +69.0%0.4%0.4 $0.68 9/30/202315,800 shares $10,892.52 +79.6%0.3%0.2 $0.69 9/15/20238,800 shares $6,688.00 +27.5%0.1%0.1 $0.76 8/31/20236,900 shares $4,637.49 -11.5%0.1%0.1 $0.67 8/15/20237,800 shares $5,588.70 +14.7%0.1%0.1 $0.72 7/31/20236,800 shares $5,576.68 -26.9%0.1%0 $0.82 7/15/20239,300 shares $7,786.89 -35.9%0.2%0 $0.84 6/30/202314,500 shares $13,735.85 -74.6%0.3%0 $0.95 6/15/202357,000 shares $63,270.00 -39.8%1.0%0.1 $1.11 5/31/202394,700 shares $99,435.00 +38.5%1.6%0.1 $1.05 5/15/202368,400 shares $77,292.00 -26.8%1.2%0.1 $1.13 4/30/202393,400 shares $100,872.00 -44.9%2.2%0.1 $1.08 3/31/2020100 shares $2,334.00 -90.0%N/A0 $23.34 3/13/20201,000 shares $25,500.00 -9.1%N/A0.2 $25.50 2/28/20201,100 shares $37,609.00 +450.0%N/A0.1 $34.19 2/14/2020200 shares $7,470.00 -71.4%N/A0 $37.35 1/31/2020700 shares $25,305.00 +600.0%N/A0.1 $36.15 1/15/2020100 shares $3,832.00 No ChangeN/A0 $38.32 12/31/2019100 shares $3,940.00 -83.3%N/A0 $39.40 REVB Short Interest - Frequently Asked Questions What is Revelation Biosciences' current short interest? Short interest is the volume of Revelation Biosciences shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 47,100 shares of REVB short. 2.89% of Revelation Biosciences' shares are currently sold short. Learn More on Revelation Biosciences' current short interest. What is a good short interest percentage for Revelation Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.89% of Revelation Biosciences' floating shares are currently sold short. Is Revelation Biosciences' short interest increasing or decreasing? Revelation Biosciences saw a decline in short interest in the month of July. As of July 15th, there was short interest totaling 47,100 shares, a decline of 44.3% from the previous total of 84,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Revelation Biosciences' float size? Revelation Biosciences currently has issued a total of 1,630,000 shares. Some of Revelation Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Revelation Biosciences currently has a public float of 1,630,000 shares. How does Revelation Biosciences' short interest compare to its competitors? 2.89% of Revelation Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Revelation Biosciences: NeuroSense Therapeutics Ltd. (1.11%), Aeterna Zentaris Inc. (0.18%), Agile Therapeutics, Inc. (12.68%), Pieris Pharmaceuticals, Inc. (0.84%), Moleculin Biotech, Inc. (0.96%), ABVC BioPharma, Inc. (1.60%), Elevai Labs, Inc. (0.87%), Cyclerion Therapeutics, Inc. (0.83%), Molecular Templates, Inc. (3.14%), Purple Biotech Ltd (1.60%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Revelation Biosciences stock? Short selling REVB is an investing strategy that aims to generate trading profit from Revelation Biosciences as its price is falling. REVB shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Revelation Biosciences? A short squeeze for Revelation Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of REVB, which in turn drives the price of the stock up even further. How often is Revelation Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including REVB, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: NRSN Short Interest AEZS Short Interest AGRX Short Interest PIRS Short Interest MBRX Short Interest ABVC Short Interest ELAB Short Interest CYCN Short Interest MTEM Short Interest PPBT Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:REVB) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revelation Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revelation Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.